FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205109602> ?p ?o ?g. }

• W4205109602 abstract "In the present study, we longitudinally monitored leukocyte subsets, expression of neutrophil surface adhesion molecules (CD62L and CD11b) and serum analytes in therapy-naïve patients with active giant cell arteritis (GCA). We collected blood samples at the baseline, and at weeks 1, 4, 12, 24, and 48 of follow-up, and evaluated short- and long-term effects of glucocorticoids (GC) vs. GC and leflunomide. Our aim was to identify candidate biomarkers that could be used to monitor disease activity and predict an increased risk of a relapse. Following high doses of GC, the numbers of CD4+ T-lymphocytes and B-lymphocytes transiently increased and then subsided when GC dose tapering started at week 4. In contrast, the numbers of neutrophils significantly increased during the follow-up time of 12 weeks compared to pre-treatment time. Neutrophil CD62L rapidly diminished after initiation of GC therapy, however its expression remained low at week 48, only in patients under combinatorial therapy with leflunomide. Levels of acute phase reactant SAA and IL-6 decreased significantly after treatment with GC and leflunomide, while levels of IL-8, IL-18, and CHI3L1 did not change significantly during the follow-up period. CHI3L1 was associated with signs of transmural inflammation and vessel occlusion and might therefore serve as a marker of fully developed active GCA, and a promising therapeutic target. Patients with relapses had higher levels of IL-23 at presentation than patients without relapses (p = 0.021). Additionally, the levels of IL-23 were higher at the time of relapse compared to the last follow-up point before relapse. IL-23 might present a promising biomarker of uncontrolled and active disease and could give early indication of upcoming relapses." @default.
• W4205109602 created "2022-01-26" @default.
• W4205109602 creator A5034357974 @default.
• W4205109602 creator A5037209090 @default.
• W4205109602 creator A5043580027 @default.
• W4205109602 creator A5049303926 @default.
• W4205109602 creator A5054914558 @default.
• W4205109602 creator A5060748260 @default.
• W4205109602 creator A5061469306 @default.
• W4205109602 creator A5065649694 @default.
• W4205109602 creator A5082312542 @default.
• W4205109602 creator A5084185428 @default.
• W4205109602 date "2022-01-20" @default.
• W4205109602 modified "2023-09-25" @default.
• W4205109602 title "From Active to Non-active Giant Cell Arteritis: Longitudinal Monitoring of Patients on Glucocorticoid Therapy in Combination With Leflunomide" @default.
• W4205109602 cites W1654976680 @default.
• W4205109602 cites W1987316799 @default.
• W4205109602 cites W2012858896 @default.
• W4205109602 cites W2022917731 @default.
• W4205109602 cites W2027322373 @default.
• W4205109602 cites W2031517139 @default.
• W4205109602 cites W2033981053 @default.
• W4205109602 cites W2101528090 @default.
• W4205109602 cites W2132732628 @default.
• W4205109602 cites W2140549929 @default.
• W4205109602 cites W2154147815 @default.
• W4205109602 cites W2206968316 @default.
• W4205109602 cites W2211731027 @default.
• W4205109602 cites W2292169217 @default.
• W4205109602 cites W2377580241 @default.
• W4205109602 cites W2593225430 @default.
• W4205109602 cites W2737436316 @default.
• W4205109602 cites W2790164088 @default.
• W4205109602 cites W2792233997 @default.
• W4205109602 cites W2793684398 @default.
• W4205109602 cites W2801743148 @default.
• W4205109602 cites W2802777075 @default.
• W4205109602 cites W2805159812 @default.
• W4205109602 cites W2810935419 @default.
• W4205109602 cites W2886154050 @default.
• W4205109602 cites W2887658487 @default.
• W4205109602 cites W2888628098 @default.
• W4205109602 cites W2904430253 @default.
• W4205109602 cites W2912824424 @default.
• W4205109602 cites W2914113570 @default.
• W4205109602 cites W2917743400 @default.
• W4205109602 cites W2919147531 @default.
• W4205109602 cites W2947522909 @default.
• W4205109602 cites W2947638359 @default.
• W4205109602 cites W2954943567 @default.
• W4205109602 cites W2964631535 @default.
• W4205109602 cites W3011394138 @default.
• W4205109602 cites W3047436630 @default.
• W4205109602 cites W3171269711 @default.
• W4205109602 cites W3210394332 @default.
• W4205109602 doi "https://doi.org/10.3389/fmed.2021.827095" @default.
• W4205109602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35127774" @default.
• W4205109602 hasPublicationYear "2022" @default.
• W4205109602 type Work @default.
• W4205109602 citedByCount "4" @default.
• W4205109602 countsByYear W42051096022023 @default.
• W4205109602 crossrefType "journal-article" @default.
• W4205109602 hasAuthorship W4205109602A5034357974 @default.
• W4205109602 hasAuthorship W4205109602A5037209090 @default.
• W4205109602 hasAuthorship W4205109602A5043580027 @default.
• W4205109602 hasAuthorship W4205109602A5049303926 @default.
• W4205109602 hasAuthorship W4205109602A5054914558 @default.
• W4205109602 hasAuthorship W4205109602A5060748260 @default.
• W4205109602 hasAuthorship W4205109602A5061469306 @default.
• W4205109602 hasAuthorship W4205109602A5065649694 @default.
• W4205109602 hasAuthorship W4205109602A5082312542 @default.
• W4205109602 hasAuthorship W4205109602A5084185428 @default.
• W4205109602 hasBestOaLocation W42051096021 @default.
• W4205109602 hasConcept C126322002 @default.
• W4205109602 hasConcept C203014093 @default.
• W4205109602 hasConcept C2775905006 @default.
• W4205109602 hasConcept C2776015282 @default.
• W4205109602 hasConcept C2776712624 @default.
• W4205109602 hasConcept C2777575956 @default.
• W4205109602 hasConcept C2779134260 @default.
• W4205109602 hasConcept C2780841215 @default.
• W4205109602 hasConcept C71924100 @default.
• W4205109602 hasConcept C90924648 @default.
• W4205109602 hasConceptScore W4205109602C126322002 @default.
• W4205109602 hasConceptScore W4205109602C203014093 @default.
• W4205109602 hasConceptScore W4205109602C2775905006 @default.
• W4205109602 hasConceptScore W4205109602C2776015282 @default.
• W4205109602 hasConceptScore W4205109602C2776712624 @default.
• W4205109602 hasConceptScore W4205109602C2777575956 @default.
• W4205109602 hasConceptScore W4205109602C2779134260 @default.
• W4205109602 hasConceptScore W4205109602C2780841215 @default.
• W4205109602 hasConceptScore W4205109602C71924100 @default.
• W4205109602 hasConceptScore W4205109602C90924648 @default.
• W4205109602 hasFunder F4320322554 @default.
• W4205109602 hasLocation W42051096021 @default.
• W4205109602 hasLocation W42051096022 @default.
• W4205109602 hasLocation W42051096023 @default.
• W4205109602 hasLocation W42051096024 @default.
• W4205109602 hasOpenAccess W4205109602 @default.
• W4205109602 hasPrimaryLocation W42051096021 @default.

• next